.
BioEnterprise

NDI

NDI is s a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice
technologies that are intended to restore lost neurological function, prevent damage and reduce the painful effects of disease and injury. NDI provides the capital to: identify and develop technologies, launch and grow companies, and take them to successful exits. In 2008, NDI sold its first product to Medtronic for $42 million.

Funding

Angels, Grants

Stage

Commercial